Day 2, Sessions IX and X


SESSION IX: Who is Investing in Epilepsy and CNS Therapy Research and Innovation Today? Funding Beyond Angels, Grants and Awards, moderated by Casey Lynch, Managing Director, NeuroInsights, LLC, Neurotechnology Industry Organization (NIO), CEO, Cortexyme, Inc.
Start at 0:12

This 3 panel session includes:

  • Greg Simon, CEO, Poliwogg
  • Manuel O. Lopez-Figueroa, PhD, Vice President, Bay City Capital, Scientific Liason, Pritzker Neuropsychiatric Disorders Research Consortium
  • Sigrid Van Bladel, PhD, Venture Partner, Aberdare Ventures

SESSION X: Shark Tank Competition, moderated by Jacqueline French, MD.
Starts at 1:09:54 

The shark tank finalists are:

  • Shower Power -- Bathing Safety Monitoring System
    Jon Davis, Inventor
    Starts at 1:22:17
  • Mc10 'Biostamp' Wearable Sensors: Wireless Convulsion and Seizure Sensing for Epilepsy Patients
    Nirav Sheth, Head of Medical Market Development, Mc10, Inc.
    Starts at 1:37:00
  • WebEase -- Y: Enhance Youth Epilepsy Management Behaviors
    Sandra L. Helmers, MD, MPH, Professor of Neurology and Pediatrics, Emory University School of Medicine
    Starts at 1:58:13
  • An In-home and Inexpensive Anti-epileptic Drug Monitoring Device Using Saliva
    Oren Knopfmacher, PhD, Avails Medical, Inc.
    Starts at 2:17:05
  • Using Smartphones to Detect Seizures (Seizario app)
    Ahmed Helmy, Associate Professor, Computer and Information Science and Engineering (CISE) Department, University of Florida 
    Amir Helmy, Co-Designer and Developer, Seizario App
    Starts at 2:33:24
  • Ketonix Breath Ketone Analyzer
    Michel Lundell, M Object Oriented Software Engineering AB
    Starts 2:49:48

Closing Remarks by Philip Gattone, President and CEO, Epilepsy Foundation
Starts at 3:32:30

<< Previous Video:
Day 2, Clinical Stage Drugs

2014 Epilepsy Pipeline Conference

On June 5-7, 2014 in San Francisco, CA, the Epilepsy Therapy Project, an initiative of the Epilepsy Foundation presented the 4th Biennial Epilepsy Pipeline Conference 2014, held at the Hyatt Regency, San Francisco.

Showcasing the most promising epilepsy therapies from healthcare companies dedicated to pioneering and advancing drugs, biologics, technologies and devices for epilepsy and seizures, this year's conference featured the third annual "Shark Tank" competition, in addition to a day designated for people with epilepsy, families and advocates. The conference brought together decision-makers with a stake in the field of epilepsy treatment, therapeutic innovation and product development. Speakers and attendees included emerging biotech and medical technology companies, major pharmaceutical and device companies, and researchers and innovators at the cutting-edge of epilepsy and CNS treatment advances.

Read the press release for more information